Form 4: electroCore Director Errico Awarded 26,615 DSUs

electroCore, Inc. Director Thomas J. Errico received an annual award of 26,615 Deferred Stock Units, increasing his total beneficial ownership to 308,016 shares.

Summary

• Thomas J. Errico, a Director of electroCore, Inc. (ECOR), was awarded 26,615 shares of Common Stock in the form of Annual Deferred Stock Units (DSUs).
• The DSUs were granted at a price of $0.00 per share.
• Following this transaction, Mr. Errico's total beneficial ownership in electroCore, Inc. stands at 308,016 shares.
• The 26,615 DSUs will vest in 12 equal monthly installments from the grant date.
• Full vesting of the DSUs will occur earlier if it's one business day prior to the Issuer's next annual stockholder meeting or immediately prior to a change of control, provided continuous service is maintained.
• Mr. Errico's beneficial ownership includes 217,051 shares owned directly, 1,296 shares by a family trust, 11,000 shares by a personal trust, and 52,054 shares from previously vested DSUs, in addition to the newly awarded 26,615 DSUs.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While a routine compensation event, the award of equity to a director increases their stake and aligns their interests with shareholders, which is generally viewed favorably. There are no negative aspects reported.

Positives

• The award of 26,615 Deferred Stock Units to a Director indicates continued alignment of management interests with shareholder value.
• An increase in beneficial ownership by a director, even through compensation, can signal confidence in the company's future prospects.

Future Outlook

The vesting schedule for the Deferred Stock Units is tied to the reporting person's continuous service and company events such as the next annual stockholder meeting or a change of control, indicating a forward-looking incentive structure.

Industry Context

This Form 4 filing reflects standard executive compensation practices within publicly traded companies, where equity awards like DSUs are used to incentivize long-term performance and align director interests with shareholders. Such awards are common in the medical device or healthcare technology sector where electroCore operates.

Comparison to Industry Standards

• The use of Deferred Stock Units (DSUs) as part of director compensation is a common practice across various industries, including the medical technology sector, aligning director incentives with long-term company performance.
• The vesting conditions, including monthly installments and accelerated vesting upon specific corporate events (annual meeting, change of control), are typical for such equity awards, comparable to practices at companies like Medtronic or Boston Scientific for their non-employee directors.

Related Party Transactions

• The award of Deferred Stock Units to a director is a form of compensation and can be considered a related party transaction as it involves a company insider.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholder value due to increased equity ownership.
• Employees: No direct impact on general employees mentioned in this filing.

Next Steps

• The Deferred Stock Units will vest in 12 equal monthly installments from the grant date.
• Full vesting will occur on the earlier of one business day prior to the Issuer's next annual stockholder meeting or immediately prior to a change of control, provided continuous service.

Key Dates

Recommendation

This Form 4 filing details a routine compensation event for a director, involving the award of Deferred Stock Units. While it increases insider ownership and aligns interests, it does not present new fundamental information or significant strategic shifts that would warrant a change in investment recommendation. It's an expected part of corporate governance and compensation practices.

Keywords

electroCore, ECOR, Deferred Stock Units, DSUs, Insider Ownership, Director Compensation, Beneficial Ownership, SEC Form 4